(NASDAQ: GEVO) Gevo's forecast annual revenue growth rate of 66.69% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 2.02%, and it is also forecast to beat the US market's average forecast revenue growth rate of 9.57%.
Gevo's revenue in 2025 is $42,034,000.On average, 2 Wall Street analysts forecast GEVO's revenue for 2025 to be $39,596,169,629, with the lowest GEVO revenue forecast at $36,538,147,997, and the highest GEVO revenue forecast at $42,654,191,260. On average, 2 Wall Street analysts forecast GEVO's revenue for 2026 to be $43,610,047,610, with the lowest GEVO revenue forecast at $39,592,576,184, and the highest GEVO revenue forecast at $47,627,519,036.
In 2027, GEVO is forecast to generate $46,641,717,312 in revenue, with the lowest revenue forecast at $41,664,796,090 and the highest revenue forecast at $51,618,638,533.